+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 6Years +
All Genders
ID06336733

Study Comparing On-demand Anakinra Versus Standard Care for Painful Attacks in Patients with Colchicine-Resistant Familial Mediterranean Fever Who Refuse Daily Therapy

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-06-25

50

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate treatments for patients with colchicine-resistant Familial Mediterranean Fever FMF who refuse continuous daily anti-IL-1 therapy. FMF is a genetic inflammatory disease causing recurrent painful attacks including abdominal pain, fever, and other symptoms. The study compares on-demand use of anakinra, a short-acting anti-IL-1 drug, with standard analgesics alongside daily colchicine to see which better reduces attack symptoms and duration in these patients. Participants will be randomly assigned to one of two groups the experimental group receives on-demand anakinra injections 100 mg daily starting from the prodromal phase of an FMF attack until 24 hours after remission, for up to 7 days, with daily colchicine and analgesics as needed. The control group receives usual analgesics combined with daily colchicine without anakinra. The study includes a 6-month treatment and follow-up period and recruits about 50 participants across multiple centers. Throughout the study, participants will be monitored at baseline, 1 month, 3 months, and 6 months. Researchers will assess the average number of FMF attacks per month as the primary outcome. Secondary outcomes include total days of attack treatment, disease activity scores, pain severity and frequency, quality of life questionnaires, injection site reactions, and adverse events. Participants will provide informed consent and undergo regular evaluations to measure treatment effects and safety over the study period.

CONDITIONS

Brief Title

Randomized Controlled Trial in Patients on Long-term Colchicine With Colchicine-resistant Familial Mediterranean Fever (FMF) to Evaluate the Efficacy of On-demand Anakinra Treatment for Painful Attacks in Patients Who Refuse Continuous Daily Therapy

Research Team

L

Léa SAVEY

S

Sophie Georgin-Lavialle, MD,PHD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here